In Vitro Toxicology Testing Market worth $20.97 billion by 2031
The report "In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031" is projected to reach USD 20.97 billion by 2031, growing from an estimated USD 12.69 billion in 2026, at a CAGR of 10.6%.
Browse 550 market data Tables and 50 Figures spread through 500 Pages and in-depth TOC on "In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testing-market-209577065.html
Technological advancements taking place in assays and equipment being used for such studies, along with the increasing R&D expenditure to undertake toxicity studies during the early stages of drug development, are aiding the adoption of in vitro testing. Stringent regulations have also been implemented across large parts of the globe to minimize animal testing, which has prompted the pharmaceutical and cosmetics industries to shift to in vitro methods for product testing. However, authorities are still reluctant to fully accept safety and efficacy data generated from non-animal methods, which is a major restraint to market growth.
The consumables segment accounted for the largest share, by product & service, of the in vitro toxicology testing market in 2025.
By offering, the in vitro toxicology testing market has been categorized into products and services. Products are further segmented into reagent & consumables, assay kits, equipment and software. The products segment accounted for a larger share than the services segment in the in vitro toxicology testing market in 2025. The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies. Additionally, the growing R&D activities in the pharmaceutical industry and the increased initiatives by governments in various countries to strengthen their product safety assessment capabilities are supporting the growth of this market.
The organ toxicity testing segment is expected to grow at the highest rate during the forecast period.
By toxicity endpoint and test, the in vitro toxicology testing market has been segmented into organ toxicity testing, cytotoxicity testing, genotoxicity testing, dermal toxicity and skin irritation, corrosion, and sensitization, oxidative stress and mechanistic toxicity, and other toxicity endpoints and tests. In 2025, the organ toxicity testing segment led the product market, supported by strong use of hepatotoxicity, cardiotoxicity, ocular toxicity, and neurotoxicity assays in early safety screening. This can be attributed to increasing regulatory demands for safety assessment and reducing animal testing, continuous advancements in cell culture and tissue engineering technologies, and increasing drug development needs.
The pharmaceutical & biotechnology companies segment accounted for the largest share in the in vitro toxicology testing services market in 2025.
By end user, the in vitro toxicology testing services market has been segmented into pharmaceutical & biotechnology companies, consumer care companies, food & beverages companies, academic and research institutes, and other end users. In 2025, pharmaceutical & biotechnology companies accounted for the largest share of the services market, supported by extensive outsourcing of cytotoxicity, genotoxicity, hepatotoxicity, cardiotoxicity, ADME-Tox, and early safety screening studies to specialized CROs and testing laboratories. This dominance is driven by the high volume of drug discovery and preclinical development programs, rising biologics and advanced therapy pipelines, and the need to identify toxic liabilities early to reduce late-stage clinical failures and development costs.
The cell culture technologies segment accounted for the largest share in the in vitro toxicology testing products market in 2025.
By technology, the in vitro toxicology testing products market has been segmented into cell culture technologies, high-throughput and high-content technologies, omics technologies, organotypic and microphysiological-based technologies, and other technologies. In 2025, the cell culture technologies segment accounted for the largest share. This is mainly because most in vitro toxicology workflows depend on cell lines, primary cells, culture media, sera, buffers, reagents, assay plates, and 2D/3D culture models for cytotoxicity, hepatotoxicity, dermal, ocular, cardiotoxicity, and neurotoxicity testing. The segment’s dominance is supported by the broad use of cell-based assays for early compound screening, safety profiling, and mechanism-of-toxicity assessment.
Europe accounted for the largest share of the in vitro toxicology testing market in 2025.
The in vitro toxicology testing market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. North America dominated the market in 2025 due to the strong presence of pharmaceutical and biotechnology companies, advanced CRO infrastructure, high R&D spending, and early adoption of cell-based assays, high-throughput screening, organ toxicity models, and predictive toxicology platforms.
Key players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), Charles River Laboratories (US), SGS SA (Switzerland), Bio-Rad Laboratories, Inc. (US), Evotec SE (Germany), Promega Corporation (US), Catalent, Inc. (US), Agilent Technologies, Inc. (US), Intertek Group plc (UK), Revvity (US), Inotiv (US), BioIVT (US), Lonza (Switzerland), Creative Biolabs (US), Shanghai Medicilon Inc. (China), Creative Bioarray (US), Aragen Life Sciences Ltd. (India), Enzo Biochem Inc. (US), Microbac Laboratories, Inc. (US), Vimta Labs Ltd. (India), Pacific BioLabs Inc. (US), and MB Research Laboratories (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the In Vitro Toxicology Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
